Try our Advanced Search for more refined results
August 16, 1999
In Re: LORAZEPAM/CLORAZE, et al v. MYLAN LABORATORIES, et al
Case Number:
1:99-mc-00276
Court:
Nature of Suit:
Judge:
Firms
- Wilson Sonsini
- Debevoise & Plimpton
- Wiley Rein
- Crowell & Moring
- Reed Smith
- Williams & Connolly
- Paul Weiss
- Foley & Lardner
- Boies Schiller
- Hunton Andrews
- NastLaw
- Pomerantz LLP
- Zwerling Schachter
- Baker & Hostetler
- Clifford Chance
- Guttman Buschner
- Hausfeld LLP
- Williams Hart
- Bennett LoCicero
- Gibson Dunn
- Proskauer Rose
- King & Spalding
- Saul Ewing
- Dorsey & Whitney
- Hogan Lovells
- Kellogg Hansen
- Robins Kaplan
- Blank Rome
- Weil Gotshal
- Leatherwood Walker
- Lowey Dannenberg
- Sheppard Mullin
- Shipman & Goodwin
- Baron & Budd
- Jenner Law
- Latham & Watkins
- Mayer Brown
Companies
- Aetna Inc.
- Cambrex Corp.
- BlueCross BlueShield of Massachusetts
- Medco Health Solutions Inc.
- BlueCross BlueShield of Texas
- Gyma Laboratories of America Inc.
- BlueCross BlueShield of New Mexico
- Health Net Inc.
- Health Care Service Corp.
- Blue Cross & Blue Shield of Minnesota
- Mutual of Omaha Insurance Co. Inc.
- Advocate Health Care Inc.
- Guardian Life Insurance Co. of America
- Trustmark Corp.
- Florida Blue
- Cardinal Health Inc.
- Independence Blue Cross Inc.
- Blue Shield of California
- Federated Mutual Insurance Co.
- Harvard Pilgrim Health Care Inc.
Government Agencies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 31, 2017
Mylan, Other Drugmakers Must Pay $67M In Antitrust Suit
The D.C. federal court has ordered generic-drug maker Mylan Pharmaceuticals and chemical companies Cambrex and Gyma Laboratories to pay a combined $67 million to Blue Cross Blue Shield of Massachusetts and three other insurers in a long-running suit accusing the three companies of violating state antitrust laws.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login